[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)

October 2009 | 102 pages | ID: E1E8D917216EN
iData Research Inc.

US$ 7,495.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The European market, as defined in this report, encompasses Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands, and Luxemburg), Scandinavia (Finland, Denmark, Sweden, and Norway), Portugal, Austria, and Switzerland. Additional products included in this report: Bioabsorbable Stents, Bifurcated Stentsand bare-metal stents.
LIST OF FIGURES

LIST OF CHARTS

RESEARCH METHODOLOGY


1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES

2.1 INTRODUCTION
2.2 CURRENCY EXCHANGE RATES
2.3 EFFECTS OF THE ECONOMIC CRISIS

COUNTRY PROFILES

3.1 INTRODUCTION
  3.1.1 Population.
  3.1.2 GDP per Capita
  3.1.3 PCI and DES Penetration Rates
  3.1.4 Price Index
3.2 GERMANY.
3.3 FRANCE.
3.4 UNITED KINGDOM
3.5 ITALY
3.6 SPAIN
3.7 BENELUX
3.8 SCANDINAVIA
3.9 PORTUGAL
3.10 AUSTRIA
3.11 SWITZERLAND.

BARE-METAL AND DRUG-ELUTING STENTS

4.1 INTRODUCTION
4.2 OVERVIEW OF THE MARKET
  4.2.1 Total Coronary Stent Market
  4.2.2 Bare-Metal versus Drug-Eluting Stents
4.3 MARKET ANALYSIS AND FORECAST
  4.3.1 Bare-Metal Stent Market
    4.3.1.1 Market Analysis and Forecast
    4.3.1.2 Bare-Metal Stent Market Drivers
    4.3.1.3 Bare-Metal Stent Market Limiters
    4.3.1.4 Bare-Metal Stent Competitive Analysis
  4.3.2 Drug-Eluting Stent Market
    4.3.2.1 Market Analysis and Forecast
    4.3.2.2 Drug-Eluting Stent Market Drivers
    4.3.2.3 Drug-Eluting Stent Market Limiters
    4.3.2.4 Drug-Eluting Stent Competitive Analysis
  4.3.3 Stents in Development.
    4.3.3.1 Bioabsorbable Stents
    4.3.3.2 Bifurcated Stents..70

LIST OF FIGURES

RESEARCH METHODOLOGY
EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
Figure 2-1: Exchange Rates for the Euro (€), 2008
COUNTRY PROFILES
Figure 3-1: Country Indicators, 2008
BARE-METAL AND DRUG-ELUTING STENTS.
Figure 4-1: Market for Coronary Stents by Type, Europe, 2005 – 2015 (€)
Figure 4-2: Market for Coronary Stents by Type, Europe, 2005 – 2015 (US$)
Figure 4-3: Market for Coronary Stents by Country, Europe, 2005 – 2015 (€)
Figure 4-4: Market for Coronary Stents by Country, Europe, 2005 – 2015 (US$)
Figure 4-5: Penetration Rate for Coronary Stents by Type, Units Sold, Europe, 2005 – 2015.
Figure 4-6: DES Penetration by Country, Europe, 2005 – 2015
Figure 4-7: Market for Bare-Metal Stents by Country, Europe, 2005 – 2015 (€).
Figure 4-8: Market for Bare-Metal Stents by Country, Europe, 2005 – 2015 (US$)48
Figure 4-9: Market Drivers and Limiters, Market for Bare-Metal Stents, Europe, 2008
Figure 4-10: Leading Competitors, Market for Bare-Metal Stents, Europe, 2008
Figure 4-11: Market for Drug-Eluting Stents by Country, Europe, 2005 – 2015 (€)56
Figure 4-12: Market for Drug-Eluting Stents by Country, Europe, 2005 – 2015 (US$)
Figure 4-13: Market Drivers and Limiters, Market for Drug-Eluting Stents, Europe, 2008
Figure 4-14: Leading Competitors, Market for Drug-Eluting Stents, Europe, 200864
Figure 4-15: Coronary Stent Platforms in Development, 2008
Figure 4-16: Potential Market for Bioabsorbable Stents, Europe, 2010 – 2015 (€)
Figure 4-17: Potential Market for Bioabsorbable Stents, Europe, 2010 – 2015 (US$)
Figure 4-18: Potential Market for Bifurcated Stents, Europe, 2010 – 2015 (€)
Figure 4-19: Potential Market for Bifurcated Stents, Europe, 2010 – 2015 (US$)

LIST OF CHARTS

RESEARCH METHODOLOGY
EUROPEAN MARKET FOR INTERVENTIONAL CARDIOLOGY DEVICES
COUNTRY PROFILES
Chart 3-1: German Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-2: French Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-3: The U.K. Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-4: Italian Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-5: Spanish Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-6: Beneluxian Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-7: Scandinavian Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-8: Portuguese Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-9: Austrian Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
Chart 3-10: Swiss Price Index, DES Penetration, Population, GDP per Capita, and PCI Penetration Rate, 2008
BARE-METAL AND DRUG-ELUTING STENTS.
Chart 4-1: Market for Coronary Stents by Type, Europe, 2005 – 2015 (€)
Chart 4-2: Penetration Rate for Coronary Stents by Type, Units Sold, Europe, 2005 – 2015.
Chart 4-3: Market for Bare-Metal Stents, Europe, 2005 – 2015 (€)
Chart 4-4: Leading Competitors, Market for Bare-Metal Stents, Europe, 2008
Chart 4-5: Market for Drug-Eluting Stents, Europe, 2005 – 2015 (€)
Chart 4-6: Leading Competitors, Market for Drug-Eluting Stents, Europe, 2008
Chart 4-7: Penetration Rate for Bioabsorbable Stents, Europe, 2010 – 2015.
Chart 4-8: Penetration Rate for Bifurcated Stents, Europe, 2010 – 2015 72


More Publications